|
Originally published In Press as doi:10.1074/jbc.M306284200 on July 8, 2003
J. Biol. Chem., Vol. 278, Issue 37, 35743-35748, September 12, 2003
The Receptor Activator of Nuclear Factor- B Ligand-mediated Osteoclastogenic Pathway Is Elevated in Amelogenin-null Mice*
Junko Hatakeyama ,
Taduru Sreenath ,
Yuji Hatakeyama ,
Tamizchelvi Thyagarajan ,
Lillian Shum ,
Carolyn W. Gibson ¶,
J. Tim Wright || and
Ashok B. Kulkarni **
From the
Functional Genomics Unit, NIDCR and the
Cartilage Biology and Orthopaedics Branch,
NIAMS, National Institutes of Health, Bethesda, Maryland 20892, the
¶Department of Anatomy and Cell Biology,
University of Pennsylvania School of Dental Medicine, Philadelphia,
Pennsylvania 19104, and the ||Department of
Pediatric Dentistry, University of North Carolina, Chapel Hill, North Carolina
27599
Amelogenins, major components of developing enamel, are predominantly
involved in the formation of tooth enamel. Although amelogenins are also
implicated in cementogenesis, their precise spatial expression pattern and
molecular role are not clearly understood. Here, we report for the first time
the expression of two alternate splice forms of amelogenins, M180 and the
leucine-rich amelogenin peptide (LRAP), in the periodontal region of mouse
tooth roots. Lack of M180 and LRAP mRNA expression correlated with cementum
defects observed in the amelogenin-null mice. The cementum defects were
characterized by an increased presence of multinucleated cells, osteoclasts,
and cementicles. These defects were associated with an increased expression of
the receptor activator of the nuclear factor- B ligand (RANKL), a
critical regulator of osteoclastogenesis. These findings indicate that the
amelogenin splice variants, M180 and LRAP, are critical in preventing abnormal
resorption of cementum.
Received for publication, June 13, 2003
, and in revised form, July 7, 2003.
* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
**
To whom correspondence should be addressed: Functional Genomics Unit, National
Institute of Dental and Craniofacial Research, National Institutes of Health,
30 Convent Drive, Bldg. 30, Rm. 527, Bethesda, MD 20892. Tel.: 301-435-2887;
Fax: 301-435-2888; E-mail:
ak40m{at}nih.gov.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Hatakeyama, S. Fukumoto, T. Nakamura, N. Haruyama, S. Suzuki, Y. Hatakeyama, L. Shum, C. W. Gibson, Y. Yamada, and A. B. Kulkarni
Synergistic Roles of Amelogenin and Ameloblastin
Journal of Dental Research,
April 1, 2009;
88(4):
318 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yagi, N. Suda, Y. Yamakoshi, O. Baba, and K. Moriyama
In vivo Application of Amelogenin Suppresses Root Resorption
Journal of Dental Research,
February 1, 2009;
88(2):
176 - 181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hatakeyama, D. Philp, Y. Hatakeyama, N. Haruyama, L. Shum, M.A. Aragon, Z. Yuan, C.W. Gibson, T. Sreenath, H.K. Kleinman, et al.
Amelogenin-mediated Regulation of Osteoclastogenesis, and Periodontal Cell Proliferation and Migration
Journal of Dental Research,
February 1, 2006;
85(2):
144 - 149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.D. Bosshardt
Are Cementoblasts a Subpopulation of Osteoblasts or a Unique Phenotype?
Journal of Dental Research,
May 1, 2005;
84(5):
390 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|